Leukemia Research
Volume 25, Issue 9 , Pages 813-820 , 1 September 2001

Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells

  • Yuki Ishii

      Affiliations

    • Department of Chemotherapy, Saitama Cancer Center, Research Institute, 818 Komuro, Ina, Saitama 362-0806, Japan
    • Institute of Biological Sciences, University of Tsukuba, Ibaraki 305-8572, Japan
  • ,
  • Shingo Sakai

      Affiliations

    • Institute of Biological Sciences, University of Tsukuba, Ibaraki 305-8572, Japan
  • ,
  • Yoshio Honma

      Affiliations

    • Department of Chemotherapy, Saitama Cancer Center, Research Institute, 818 Komuro, Ina, Saitama 362-0806, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-48-7221111; fax: +81-480-854630

Received 19 September 2000 ,Accepted 20 January 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(01)00026-1

Leukemia Research
Volume 25, Issue 9 , Pages 813-820 , 1 September 2001